<DOC>
	<DOCNO>NCT01983072</DOCNO>
	<brief_summary>The clinical trial aim show efficacy prebiotics probiotic microbiota balance . Together , prebiotic solution combination probiotic expect harmonize microbiota formula feed neonates microbiota breast fed neonates allow great diversity Bifidobacteria species comparison formula non-supplemented pre probiotic .</brief_summary>
	<brief_title>Symbiotic &amp; Colonization</brief_title>
	<detailed_description>The infant recruit randomize 0 14 day . The intervention period , term data necessary primary outcome , reach 3 month old . Measurements collect three separate occasion period , i.e . 2 6 week 3 month . Stools collect , 3 separate occasion , i.e . 4-5 day , 6 week 3 month life .</detailed_description>
	<criteria>Healthy newborn infant Full term infant ( ≥ 37 week gestation ; ≤ 42 week gestation ) Age infant 14 day time enrollment Birth weight 2500g 4500g For Formula fed group : The infant 's mother elect , 14th day child 's life , continue breastfeed ( breastfeed 14th day child 's life ) For Breastfed group : The infant 's mother elect fully breastfeed baby , enrollment least 3 month age Having obtain his/her legal representative 's informed consent Congenital illness malformation may affect normal growth Significant prenatal and/or postnatal disease Rehospitalization 2 day first 14 day life . ( Exceptionally , infant rehospitalized jaundice may enrol study ) . Newborn receive antibiotic first 14 day life Receiving infant formula contain pro and/or prebiotics time enrolment Newborn whose parent / caregiver expect comply treatment Newborn currently participate another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>colonization gastrointestinal tract bacteria</keyword>
</DOC>